Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2022 · 10-Q
Revenue$1.43M$1.43M+33.6% vs Q3 2021 Net Income-$4.53M-$4.53MN/M vs Q3 2021 EPS Diluted-$0.58-$0.58N/M vs Q3 2021 Gross Profit$366,000+297.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,104,000N/M Free Cash Flowderived-$5,330,000N/M Margins · derivedGross margin25.6%+17.0 pt vs Q3 2021
Operating margin-322.2%+54.2 pt vs Q3 2021
Net margin-316.5%+63.6 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 7, 2022 · 38 d after period end